This site is intended for UK healthcare professionals only
This webcast series and supporting materials were developed by the Chronic Conditions faculty in conjunction with OmniaMed Communications. The sponsoring companies have had no input into the agenda, speaker selection, presentations or collateral content, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible.
Adjuvanted Trivalent Influenza Vaccine ▼ Prescribing Information can be found here Cell-based Trivalent Influenza Vaccine ▼ Prescribing Information can be found here.
Prescribing information and adverse event reporting details can also be found underneath the video player on this page.
This promotional symposium was organised, funded and reviewed by CSL Seqirus for UK healthcare professionals only. CSL products were discussed in this promotional webinar.
GBR-FLU-25-0019 | June 2025
Adjuvanted Trivalent Influenza Vaccine ▼ Prescribing Information can be found here. Cell-based Trivalent Influenza Vaccine ▼ Prescribing Information can be found here.
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events relating to CSL Seqirus products should also be reported to Seqirus UK Limited on 01748 828816.
GBR-FLU-25-0019 | June 2025
For UK healthcare professionals only
Are you a UK healthcare professional?
The information is intended for UK healthcare professionals only.
Please confirm below.